SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-040652
Filing Date
2020-02-18
Accepted
2020-02-18 17:17:47
Documents
5
Effectiveness Date
2020-02-18

Document Format Files

Seq Description Document Type Size
1 S-8 d885273ds8.htm S-8 65222
2 EX-5.1 d885273dex51.htm EX-5.1 44028
3 EX-23.2 d885273dex232.htm EX-23.2 1535
4 EX-23.3 d885273dex233.htm EX-23.3 1763
5 EX-99.1 d885273dex991.htm EX-99.1 81397
  Complete submission text file 0001193125-20-040652.txt   194962
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236498 | Film No.: 20626412
SIC: 2834 Pharmaceutical Preparations